Hemoglobin News and Research RSS Feed - Hemoglobin News and Research

Male hormones can reverse biological drivers of aging, study shows

Male hormones can reverse biological drivers of aging, study shows

Telomerase, an enzyme naturally found in the human organism, is the closest of all known substances to a "cellular elixir of youth." In a recent study, Brazilian and US researchers show that sex hormones can stimulate production of this enzyme. [More]
Novel biomarkers may offer solution for detecting autologous blood transfusion in athletes

Novel biomarkers may offer solution for detecting autologous blood transfusion in athletes

Increasing oxygen delivery to muscles can help athletes perform better and give them the edge needed to win elite competitions. One of the best ways to increase oxygen supply is through blood manipulation, undergoing a blood transfusion that provides extra red blood cells and boosts oxygen levels. [More]
Critical evaluation of EKF Diagnostics’ Quo-Test analyzer released

Critical evaluation of EKF Diagnostics’ Quo-Test analyzer released

EKF Diagnostics, the global in-vitro diagnostics company, announces the release of a significant critical evaluation of the Quo-Test analyzer carried out by the European Reference Laboratory for Gylcohemoglobin. This new evaluation represents the culmination of several years’ cooperation between EKF Diagnostics and the European Reference Laboratory to produce a world class Point-of-Care-Testing (POCT) HbA1c analyzer. [More]
UCI researchers use new imaging method to measure fat metabolism

UCI researchers use new imaging method to measure fat metabolism

A team from the University of California, Irvine and supported by the National Institute of Biomedical Imaging and Bioengineering has used a new imaging technique to measure how people break down dietary fat into products the cells of their bodies can use. [More]
Liraglutide drug lowers blood sugar levels in diabetic patients taking large doses of insulin

Liraglutide drug lowers blood sugar levels in diabetic patients taking large doses of insulin

When Amy Sweat was 19 years old, while she was in the hospital recovering from surgery, she was diagnosed with Type 2 diabetes. Ms. Sweat was treated for her diabetes, first on oral drugs, then on increasingly larger doses of insulin, but the years went by and she never was able to achieve good blood sugar control. [More]
New method could help detect unconjugated bilirubin in newborn infants

New method could help detect unconjugated bilirubin in newborn infants

A research group led by Project Professor Morioka Ichiro and Assistant Professor Iwatani Sota in collaboration with Doctor Miyawaki Atsushi have clinically proven that a fluorescent protein sourced from Japanese eel muscles can be used to accurately detect unconjugated bilirubin in newborns. [More]
Circulating microRNAs may help predict risk for myocardial infarction

Circulating microRNAs may help predict risk for myocardial infarction

When you visit your general practitioner you can get your blood analyzed for cholesterol and triglycerides, to get an idea of your risk for cardiovascular disease. With additional information about BMI, smoking habits and blood pressure, this can be used to calculate your 10-year risk for cardiovascular disease. [More]
Oral aloe vera use linked to decreases in FBG and hemoglobin A1c

Oral aloe vera use linked to decreases in FBG and hemoglobin A1c

A meta-analysis of studies in people with diabetes and pre-diabetes has shown that oral aloe vera use was associated with significant decreases in both fasting blood glucose (FBG) and hemoglobin A1c (HbA1c). [More]
Experimental lipid-lowering drug improves glucose control in diabetic patients

Experimental lipid-lowering drug improves glucose control in diabetic patients

High triglycerides -- a type of fat, or lipid, in the blood -- increase the risk of heart disease and perhaps type 2 diabetes. For the first time, it has been shown that profoundly lowering triglycerides in diabetics improves their insulin sensitivity over time, which helps them maintain healthy glucose - blood sugar -- levels. [More]
Long-term opioid therapy may not be effective to manage pain in sickle cell disease patients

Long-term opioid therapy may not be effective to manage pain in sickle cell disease patients

In a small study looking at pain assessments in adults with sickle cell disease, researchers at Johns Hopkins says overall, those treated long-term with opioids often fared worse in measures of pain, fatigue and curtailed daily activities than those not on long-term opioids. [More]
Overtesting for HbA1C levels can increase risk of severe hypoglycemia

Overtesting for HbA1C levels can increase risk of severe hypoglycemia

With a more-is-better mindset common in society, frequent commercials encouraging checks of glycated hemoglobin (HbA1C) levels, and ads for new diabetes medications to lower HbA1C in adults with Type 2 diabetes, Mayo Clinic researchers were not too surprised to find overtesting occurring. [More]
Few commercial weight loss programs show promise of benefit for diabetic patients

Few commercial weight loss programs show promise of benefit for diabetic patients

Johns Hopkins scientists who indirectly investigated the blood sugar effects of 10 (out of 32 selected) commercial weight loss programs say a few show promise of benefit for diabetic patients, but far more rigorous research is needed before doctors can wholeheartedly recommend them. [More]
Could a new test improve bowel cancer screening uptake? An interview with Professor Halloran

Could a new test improve bowel cancer screening uptake? An interview with Professor Halloran

The most recent complete data for England (2014/15) shows an average uptake of the guaiac Faecal Occult Blood Tests (gFOBT) from those invited by the NHS Bowel Cancer Screening Programme (BCSP) of 58.22%. [More]

New method helps scavenge inflammatory molecules that mediate sepsis in mice

Sepsis is a life-threatening complication of infection in which the molecules that the body releases to fight an infection trigger widespread inflammatory responses, resulting in damage to multiple organ systems. [More]
Hydroxyurea treatment improves pulmonary function decline in children with sickle cell disease

Hydroxyurea treatment improves pulmonary function decline in children with sickle cell disease

For the first time, researchers were able to demonstrate that children diagnosed with sickle cell disease showed improvement in lung function after treatment with hydroxyurea, a treatment that is underused despite its demonstrated benefits. [More]
Positive effects of good nutrition linked to child's social behavior, development

Positive effects of good nutrition linked to child's social behavior, development

Proper nutrition during childhood can positively affect a child's social behaviors and development. [More]
Minihepcidins may potentially treat serious genetic blood diseases in children, adults

Minihepcidins may potentially treat serious genetic blood diseases in children, adults

New research suggests that synthetic peptides called minihepcidins may potentially treat two serious genetic blood diseases in children and adults. Although those diseases, beta-thalassemia and polycythemia vera, have opposite effects on red blood cell production, treating animals with minihepcidin helps to restore normal levels of red blood cells and reduces spleen enlargement. It also controls the accumulation of excess levels of iron in beta-thalassemia that often causes severe toxic effects. [More]
Study finds no gender-based differences on use of anticoagulation medications in TAVR patients

Study finds no gender-based differences on use of anticoagulation medications in TAVR patients

A study on the impact of using different anticoagulation medications on men and women who have undergone a transcatheter aortic valve replacement (TAVR) found no difference in early vascular complications or mortality. [More]
Globin gene transfer to treat beta-thalassemias shows promise in first clinical trial

Globin gene transfer to treat beta-thalassemias shows promise in first clinical trial

Promising results from the first clinical trials of globin gene transfer to treat beta-thalassemias-inherited forms of anemia-have eliminated the need for blood transfusions in some individuals. [More]

Philips launches IntelliVue patient monitoring system with Masimo rainbow SET technology

As part of the company’s focus on the development of advanced monitoring solutions, Royal Philips today announced the launch of its IntelliVue patient monitoring platform with Masimo rainbow SET technology. [More]
Advertisement
Advertisement